Contraception News and Research

Latest Contraception News and Research

New study looks at hormone/SNS relationship in women taking hormone contraceptives

After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. One possible contributing explanation for the change in risk is that sex hormones affect the sympathetic nervous system, which controls constriction of blood vessels and participates in the fight or flight response.

7 Nov 2013

Appeals court decision is latest blow to birth control mandate, setting up possible Supreme Court consideration

A divided federal appeals court on Friday ruled against the health law's requirement that businesses with 50 or more workers cover birth control in employee health plans.

5 Nov 2013

First Edition: November 4, 2013

Today's headlines include the latest on the efforts to address the problems with healthcare.gov, as well as the continuing controversy surrounding President Barack Obama's promise that Americans could keep their health coverage if they liked it juxtaposed with the news of recent policy cancellations.

4 Nov 2013

Appeals court rules against health law's contraception rule

News outlets covered the blow to the Obama administration's requirement that insurance policies include free coverage for women's birth control.

4 Nov 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

Results of Phase 3 clinical trial of contraceptive vaginal ring presented by Population Council

Today, the Population Council presented findings from a Phase 3 clinical trial that was designed to demonstrate the safety, efficacy, and acceptability of the Council's investigational one-year contraceptive vaginal ring (CVR).

16 Oct 2013

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.

10 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

Study: Women with eating disorders are less likely to have children

Women with eating disorders are less likely to have children than others in the same age group, indicates a study conducted at the University of Helsinki, Finland. The likelihood for miscarriage was more than triple for binge-eating disorder (BED) sufferers and the likelihood of abortion more than double for bulimics than others in the same age group.

8 Oct 2013

Supreme Court likely to rule on abortion laws, contraception mandate in new term

The Supreme Court's new session will almost certainly see a ruling on state power to limit the use of some abortion-inducing drugs and one on Arizona's law outlawing abortions after 20 weeks of pregnancy.

8 Oct 2013

PMDD may shed light on complex interactions between sex hormones and mood

Improved understanding of the role of female sex hormones on the drivers and symptoms of premenstrual dysphoric disorder (PMDD) may shed light on the complex interactions between sex hormones and mood, potentially helping to explain the increased prevalence of mood disorders in women.

8 Oct 2013

First Edition: October 7, 2013

Today's headlines include reports detailing the ins and outs of the federal government's online health insurance markeplace as well as the latest from Capitol Hill on the shutdown.

7 Oct 2013

Viewpoints: Marketplaces offer Americans the kind of shopping they like; enrollment isn't as robust as administration claims

Americans have grown accustomed to online comparison shopping, as the overwhelming number who clicked on health-exchange websites demonstrates.

5 Oct 2013

Viewpoints: Obamacare marketplaces' 'first-day jitters'; the need for healthy young adults to enroll

The insurance-buying exchanges created by the 2010 health care law stumbled out of the gate Tuesday, or at least their websites did. In California, online sign-up pages loaded haltingly or not at all throughout the day. The problems weren't severe enough to stop determined applicants, as long as they didn't mind having their patience tested. But they were a sign that the system wasn't ready to handle the volume of inquiries it received on Day One (Jon Healey, 10/1).

3 Oct 2013

Opinions on shutdown: Boehner says Dems have 'slammed the door;' GOP effort to derail law takes democracy 'hostage'

The president isn't telling the whole story when it comes to the government shutdown. The fact is that Washington Democrats have slammed the door on reopening the government by refusing to engage in bipartisan talks. And, as stories across the country highlight the devastating impact of Obamacare on families and small businesses, they continue to reject our calls for fairness for all Americans (House Speaker John Boehner, R-Ohio, 10/2).

3 Oct 2013

Comments on shutdown: Both parties are shirking their duties; this fight may hold off health law battle on debt ceiling

Yes, defaulting on the U.S. debt would be worse than shutting down the government. But both represent such recklessly, breathtakingly, wastefully irresponsible derelictions of leadership that the people who run this town ought to be ashamed of themselves if either comes to pass.

1 Oct 2013

Women should tackle hormonal chaos, seek treatment for perimenopausal symptoms

Women should address the "hormonal chaos" of their 40s and not be afraid to seek treatment for perimenopausal symptoms, advises an internationally recognized expert in reproductive endocrinology from Wake Forest Baptist Medical Center.

27 Sep 2013

Longer looks: Dangers of too much Tylenol; emergency contraception for Native Americans; death dinners

During the last decade, more than 1,500 Americans died after accidentally taking too much of a drug renowned for its safety: acetaminophen, one of the nation's most popular pain relievers. Acetaminophen – the active ingredient in Tylenol – is considered safe when taken at recommended doses. Tens of millions of people use it weekly with no ill effect. But in larger amounts, especially in combination with alcohol, the drug can damage or even destroy the liver (Jeff Gerth and T. Christian Miller, 9/20).

27 Sep 2013

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

President Obama, President Clinton, and Senator Ted Cruz all spent a lot of time talking about Obamacare on Tuesday. But the real news came just as the day was ending, right at midnight, when the Department of Health and Human Services released data on insurance premiums available through the new Obamacare marketplaces. Several states had already released their data. With this report, HHS provided premium information for most of the rest. Overall, the numbers are pretty consistent with previous reports, albeit with some new and interesting wrinkles. It seems like mostly good news, though the law's critics would argue it vindicates some of their arguments, as well (Jonathan Cohn, 9/25).

26 Sep 2013

Contraception News and Research

Latest Contraception News and Research

New study looks at hormone/SNS relationship in women taking hormone contraceptives

Appeals court decision is latest blow to birth control mandate, setting up possible Supreme Court consideration

First Edition: November 4, 2013

Appeals court rules against health law's contraception rule

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Results of Phase 3 clinical trial of contraceptive vaginal ring presented by Population Council

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Bayer HealthCare receives FDA approval for Adempas tablets

Study: Women with eating disorders are less likely to have children

Supreme Court likely to rule on abortion laws, contraception mandate in new term

PMDD may shed light on complex interactions between sex hormones and mood

First Edition: October 7, 2013

Viewpoints: Marketplaces offer Americans the kind of shopping they like; enrollment isn't as robust as administration claims

Viewpoints: Obamacare marketplaces' 'first-day jitters'; the need for healthy young adults to enroll

Opinions on shutdown: Boehner says Dems have 'slammed the door;' GOP effort to derail law takes democracy 'hostage'

Comments on shutdown: Both parties are shirking their duties; this fight may hold off health law battle on debt ceiling

Women should tackle hormonal chaos, seek treatment for perimenopausal symptoms

Longer looks: Dangers of too much Tylenol; emergency contraception for Native Americans; death dinners

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Contraception News and Research

Latest Contraception News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in